- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2018
- Public Summary Document (PSD) July 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2018 PBAC Meeting - Word
Golimumab – July 2018
Golimumab: Injection 50 mg in 0.5 ml single use pre filled syringe (Simponi); Injection 50 mg in 0.5
Last updated
26 October 2018